This product is intended strictly for laboratory research and analytical purposes only.
These products are not intended for human or animal consumption, nor for use in clinical or therapeutic applications. While some specific peptide-based medications have received FDA approval for medical use, the research-grade products provided here have not been evaluated, tested, or approved by the FDA or any other regulatory authority for safety, efficacy, or suitability for human or animal use.
Product name: PEG-MGF
Physical form: lyophilised solid
Purity: 99%
Molecular Type: Pegylated Synthetic peptide
Chain length: 24 Amino acids
Molecular formula: C₁₂₁ H₂₀₀ N₄₂ O₃₉
Molecular weight: – 2867.2 g/mol
Primary identifier: CAS# 108174-48-7
PEG-MGF (Pegylated Mechano Growth Factor) is a synthetic splice variant of the insulin-like growth factor-1 (IGF-1) gene, specifically engineered with a polyethylene glycol (PEG) moiety to enhance its stability and metabolic half-life in physiological environments. In experimental research, this compound is primarily investigated for its capacity to serve as a potent local anabolic agent, functioning by activating satellite cells—the stem cells of muscle tissue—to facilitate the repair and growth of skeletal muscle fibers following mechanical loading or trauma. Studies explore its role in mediating myoblast proliferation and differentiation, which are essential processes for sarcolemmal repair and muscle hypertrophy. Furthermore, because the PEGylation process protects the peptide from rapid degradation in the bloodstream, it provides a more sustained biological effect compared to non-pegylated variants in research models. As an investigational research-grade chemical, PEG-MGF is strictly utilized within controlled scientific settings.
This product is intended strictly for laboratory research and analytical purposes only.
CoA available
